Overview Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men Status: Completed Trial end date: 2010-09-01 Target enrollment: Participant gender: Summary The study will evaluate the pharmacokinetics of testosterone transdermal systems at steady-state in hypogonadal men. Phase: Phase 1 Details Lead Sponsor: Watson PharmaceuticalsTreatments: MethyltestosteroneTestosteroneTestosterone 17 beta-cypionateTestosterone enanthateTestosterone undecanoate